Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma
Clinical trial NCT02059239 · COMPLETED
Trial details
- NCT number
- NCT02059239
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-04
- Primary completion
- 2019-12-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.